Alexander Monto
Overview
Explore the profile of Alexander Monto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
822
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luk J, Ha N, Shui A, Snyder H, Batki S, Ostacher M, et al.
Alcohol Clin Exp Res (Hoboken)
. 2024 Dec;
49(1):244-255.
PMID: 39632077
Background: Alcohol use disorder (AUD) treatment can help improve clinical outcomes among patients with alcohol-associated cirrhosis but is underutilized. Among socioeconomically disadvantaged patients with alcohol-associated cirrhosis, we examined rates of...
2.
Satre D, Dasarathy D, Batki S, Ostacher M, Snyder H, Hua W, et al.
Aliment Pharmacol Ther
. 2024 Nov;
61(3):481-490.
PMID: 39523996
Background And Aims: Alcohol use is prevalent among hepatology clinic patients with chronic liver disease (CLD). We explored factors associated with the importance and confidence dimensions of motivation to reduce...
3.
Athavale P, Wong R, Satre D, Monto A, Cheung R, Chen J, et al.
Gastro Hep Adv
. 2024 Aug;
3(2):201-209.
PMID: 39129958
Background And Aims: Telehealth has emerged as an important mode of cirrhosis care delivery, but its use and satisfaction among vulnerable populations (eg, racial/ethnic minorities, socioeconomically disadvantaged, substance use disorders)...
4.
Ryan J, Haight C, Niemi E, Grab J, Dodge J, Lanier L, et al.
Eur J Immunol
. 2024 May;
54(8):e2350678.
PMID: 38700055
Background And Aims: Second-generation direct-acting antivirals (2G DAA) to cure HCV have led to dramatic clinical improvements. HCV-associated hepatocellular carcinoma (HCC), however, remains common. Impaired immune tumor surveillance may play...
5.
Luk J, Satre D, Cheung R, Wong R, Monto A, Chen J, et al.
Hepatol Commun
. 2024 Feb;
8(2).
PMID: 38315141
Background: Management of cirrhosis is challenging and has been complicated by the COVID-19 pandemic due to decreased access to care, increased psychological distress, and alcohol misuse. Recently, The National Institute...
6.
Kim R, Patel S, Satre D, Shumway M, Chen J, Magee C, et al.
Dig Dis Sci
. 2024 Jan;
69(3):732-742.
PMID: 38217682
Background: Since the coronavirus disease 2019 (COVID-19) pandemic began, telemedicine use has transformed healthcare delivery. Yet there is concern that telemedicine may widen care disparities for vulnerable populations, and patient...
7.
Schwab M, Decker H, Monto A, Sawhney R, Corvera C
JAMA Surg
. 2023 Dec;
159(3):345-347.
PMID: 38150246
No abstract available.
8.
Wong R, Yang Z, Ostacher M, Zhang W, Satre D, Monto A, et al.
Am J Med
. 2023 Dec;
137(3):236-239.e2.
PMID: 38052382
Background: Veterans may be especially susceptible to increased alcohol consumption following the COVID-19 pandemic. We aim to evaluate trends in alcohol use among US Veterans prior to, during, and following...
9.
Rogal S, Taddei T, Monto A, Yakovchenko V, Patton H, Merante M, et al.
Clin Gastroenterol Hepatol
. 2023 Jul;
22(2):324-338.
PMID: 37460005
Background & Aims: The coronavirus disease-2019 pandemic profoundly disrupted preventative health care services including cancer screening. As the largest provider of cirrhosis care in the United States, the Department of...
10.
Parikh R, Hebbe A, Baron A, Grunwald G, Plomondon M, Gordin J, et al.
J Am Heart Assoc
. 2023 Feb;
12(4):e028082.
PMID: 36789851
Background Clinical characteristics and outcomes in people living with HIV (PLWH) undergoing percutaneous coronary intervention (PCI) remain poorly described. We sought to compare real-world treatment of coronary artery disease, as...